Kaira Can (504840)

Score breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1

Key Financials

Strengths

• Meaningful tangible asset backing: book value ₹1,005 per share, so P/B is 1.88 not 10 times.
• Existing revenue base: latest quarterly sales of ₹53 Cr, giving the company a foundation to potentially recover.
• Small-cap packaging business with a modest market cap of ₹174 Cr, so even small profit recovery could move earnings per share.
• It still pays a dividend, though the 0.87% yield is thin.

Concerns

• Profit growth has collapsed by 121.88%, and latest quarterly net profit is essentially zero.
• ROE of 3.66% and ROCE of 5.94% are far below acceptable hurdle rates for equity investors.
• Sales are declining at -3.99%, so the business is shrinking, not growing.
• Piotroski F-score of 3/9 signals weak fundamental health.

AI Analysis

At ₹1,890, Kaira Can trades at 40.2 times earnings for a business whose profit growth has collapsed by 121.88%. I don’t need a complex story to stay cautious. The latest quarter shows sales of ₹53 Cr and net profit of essentially zero—no current earnings power. Book value is ₹1,005 per share, so at 1.88 times book, I would be paying a healthy premium for assets that earn only a 3.66% return on equity. That is a miserable return; even a fixed deposit would be more appealing. The ROCE of 5.94% is also far below what I demand from a packaging business. Sales are shrinking about 4%, and the Piotroski score of 3/9 suggests weak financial health. Dividend yield of 0.87% gives little income support. This may be a cyclical packaging company at the bottom of a profit cycle—in that case, the high P/E is caused by depressed earnings, not proof of value. But the stock sits at the top of its 52-week range: ₹1,890 versus a ₹1,120 low. Mr. Market has marked the price up while fundamentals deteriorated. As Graham said, price is what you pay, value is what you get. What would I get here? A low-ROE, near-zero-profit business at 1.88 times book, with no margin of safety. I would need a much lower price or clear evidence of recovery before considering this. Watch and wait.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer